This meeting is intended for gynecologic oncologists, medical oncologists, radiation oncologists, obstetrician/gynecologists, fellows and residents in these areas, research scientists, nurses, nurse practitioners, physician assistants, allied health professionals and other clinicians involved in the care of patients with gynecologic malignancies.
- Identify and explain the latest trends in global research, methods, and technology in the treatment of gynecologic cancers.
- Interpret contemporary research findings on the prevention of and screening for gynecologic cancers and be able to appropriately implement changes into clinical practice by the health care providers team.
- Examine the significance of novel approaches to the medical and surgical management of gynecologic cancers within the context of the current standard of care.
- Be able to integrate new therapies into clinical practice in an evidence-based manner.
- Be able to amplify implementation of novel approaches to the clinical care team.
- Incorporate multi-disciplinary approaches to complex gynecologic cancers to improve outcomes.
- Assess the implications for future research and clinical practice of new developments in translational research on gynecologic cancers, and
- Demonstrate improvement in competence, performance, and patient outcomes.
SGO has earned full accreditation from the Joint Accreditation Council, which includes the ACCME, ACPE, and ANCC. Acquiring this status ensures that SGO’s educational activities and products are free from commercial bias and based on valid content by the healthcare team for the healthcare team. Activities that are designated with CE credit ensures the multidisciplinary health care community and the public that such activities provide the healthcare oncology team with information that can assist them in maintaining or improving their practice of medicine. An important element of Joint Accreditation compliance is disclosing and resolving any potential conflicts of interest between a presenter and a corporate entity. All conflicts identified will be resolved following SGO’s board approved policies on conflict resolution. Activities and products with accreditation attached equate to a fair and balanced educational experience.
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Society of Gynecologic Oncology or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.
In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement – Physician
This activity is approved for 26.0 AMA PRA Category 1 Credits™
ANCC Credit Designation Statement – Nurses
This CE activity is approved for 25.5 ANCC Contact hours
ACPE Credit Designation Statement – Pharmacists
This activity is approved for 21.0 ACPE contact hours (CEUs)
ACPE UAN: JA0007238-0000 (18)-006-L01 -P
PAs may claim a maximum of Category 1 credits (21.0) for completing this activity. NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state or medical society.